The study will compare the therapeutic efficacy of surgery, radiation and HSV-Tk1 vector producer cells (VPC) followed by ganciclovir with the efficacy of surgery and radiation in patients with newly diagnosed, previously untreated glioblastoma.
Showing the most recent 10 out of 381 publications